Where possibilities become realities.
TriMetis Life Sciences is a preclinical services company dedicated to helping you accelerate your research through access to quality biospecimens, innovative technology and research expertise.
Proprietary imaging technology for evaluating Quality of Slides and FFPE Blocks - % tumor, % necrosis...
Proprietary imaging technology to assess region of interest (ROI) for selection of tumor content for NextGen Sequencing
Leverage our global access for accurate and timely delivery.
DIGITAL IMAGE LIBRARIES
Leverage Digital Image Libraries for Ai Biomarker Development
Accelerate your product's unique development.
Request a risk assessment for your product.
TriMetis is a preclinical services company helping medical device, pharmaceutical, and biotech companies and academic institutions advance their research through biospecimen procurement and specialty laboratory and consultation services.
Through TriMetis’ work in biospecimen research and procurement, we have invested and developed an innovative machine learning application for the identification of the region of interest for the highest abundance of tumor tissue. We have implemented this process directly into our workflow, by replacing the need for pathologists to manually circle regions of interest for microdissection. The automation allows for greater throughput of specimens for NextGen Sequencing, saving our clients time and money while providing superior specimens.
Our consultants have extensive expertise in business strategy and development consulting, medical writing, protocol development, quality assurance and training, and project management services.
Contact us today to learn how we can help you elevate your research!
20 South Dudley Street, Suite 806
Tel: +1 (901) 866 1818